The transcription factor IRF4 represses proapoptotic BMF and BIM to licence multiple myeloma survival.
Fedele PL, Liao Y, Gong JN, Yao Y, van Delft MF, Low MSY, Tai L, Herold MJ, Jackson JT, Teh CE, Tan T, O'Reilly LA, Tellier J, Grigoriadis G, Huang DCS, Shi W, Nutt SL, Willis SN.
Fedele PL, et al. Among authors: shi w.
Leukemia. 2021 Jul;35(7):2114-2118. doi: 10.1038/s41375-020-01078-0. Epub 2020 Nov 4.
Leukemia. 2021.
PMID: 33149265
No abstract available.